Chimerix, Inc. , a biopharmaceutical company developing novel, oral antivirals in areas of high unmet medical need, today announced that Kenneth I. Moch, President and CEO of Chimerix, will present at the 25th Annual Piper Jaffray Healthcare Conference on Wednesday, December 4, 2013 at 9:00 am ET at the New York Palace Hotel in New York City.
http://www.globenewswire.com/news-release/2013/11/26/592713/10059670/en/Chimerix-to-Present-at-25th-Annual-Piper-Jaffray-Healthcare-Conference.html
http://www.globenewswire.com/news-release/2013/11/26/592713/10059670/en/Chimerix-to-Present-at-25th-Annual-Piper-Jaffray-Healthcare-Conference.html
No comments:
Post a Comment